Dual targeting of solid lipid nanoparticles grafted with 83-14 MAb and anti-EGF receptor for malignant brain tumor therapy

Life Sciences

Volumn 146, Issue , 2016, Pages 222-231

  Kuo, Yung Chih ^a   Lee, Chia Hao ^a  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

83 14 monoclonal antibody; Anti epithelial growth factor receptor; Blood brain barrier; Etoposide; Glioblastoma multiforme; Solid lipid nanoparticle

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; ETOPOSIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 83-14; PROPIDIUM IODIDE; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; NANOPARTICLE;

ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CANCER GROWTH; CANCER INHIBITION; CANCER THERAPY; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONTROLLED STUDY; CROSS LINKING; DRUG CONJUGATION; DRUG SYNTHESIS; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PARTICLE SIZE; PHYSICAL CHEMISTRY; TRANSENDOTHELIAL ELECTRICAL RESISTANCE; ZETA POTENTIAL; ANTAGONISTS AND INHIBITORS; BRAIN NEOPLASMS; CAPILLARY; CELL LINE; CELL SURVIVAL; CYTOLOGY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; IMPEDANCE; METABOLISM;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ASTROCYTES; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CAPILLARIES; CELL LINE; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; ETOPOSIDE; GLIOBLASTOMA; HUMANS; NANOPARTICLES; PARTICLE SIZE; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84955491083     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2016.01.025     Document Type: Article

References (58)

1. T.A. Dolecek, J.M. Propp, N.E. Stroup, and C. Kruchko CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009 Neuro-Oncology 14 2012 v1 v49
2. A.A. Argyriou, A. Antonacopoulou, G. Iconomou, and H.P. Kalofonos Treatment options for malignant gliomas, emphasizing towards new molecularly targeted therapies Crit. Rev. Oncol. Hematol. 69 2009 199 210
3. P.Y. Wen, and S. Kesari Malignant gliomas in adults N. Engl. J. Med. 359 2008 492 507
4. K.M. Kroeger, A.K. Muhammad, G.J. Baker, H. Assi, M.K. Wibowo, W. Xiong, K. Yagiz, M. Candolfi, P.R. Lowenstein, and M.G. Castro Gene therapy and virotherapy: novel therapeutic approaches for brain tumors Discov. Med. 10 2010 293 304
5. M. Preusser, S. de Ribaupierre, A. Wohrer, S.C. Erridge, M. Hegi, M. Weller, and R. Stupp Current concepts and management of glioblastoma Ann. Neurol. 70 2011 9 21
6. M.E. Halatsch, U. Schmidt, J. Behnke-Mursch, A. Unterberg, and C.R. Wirtz Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours Cancer Treat. Rev. 32 2006 74 89
7. N. Shinojima, K. Tada, S. Shiraishi, T. Kamiryo, M. Kochi, H. Nakamura, K. Makino, H. Saya, H. Hirano, J. Kuratsu, K. Oka, Y. Ishimaru, and Y. Ushio Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme Cancer Res. 63 2003 6962 6970
8. J. Baselga The EGFR as a target for anticancer therapy - focus on cetuximab Eur. J. Cancer 37 2001 16 22
9. L. Li, T.S. Quang, E.J. Gracely, J.H. Kim, J.G. Emrich, T.E. Yaeger, J.M. Jenrette, S.C. Cohen, P. Black, and L.W. Brady A phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme J. Neurosurg. 113 2010 192 198
10. M. Bredel Anticancer drug resistance in primary human brain tumors Brain Res. Rev. 35 2001 161 204
11. Y.C. Kuo, and C.H. Lu Expression of P-glycoprotein and multidrug resistance-associated protein on human brain-microvascular endothelial cells with electromagnetic stimulation Colloids Surf. B 91 2012 57 62
12. L.H. Dieu, D. Wu, C.G. Palivan, V. Balasubramanian, and J. Huwyler Polymersomes conjugated to 83-14 monoclonal antibodies: in vitro targeting of brain capillary endothelial cells Eur. J. Pharm. Biopharm. 88 2014 316 324
13. A.S. Manjappa, K.R. Chaudhari, M.P. Venkataraju, P. Dantuluri, B. Nanda, C. Sidda, K.K. Sawant, and R.S. Ramachandra Murthy Antibody derivatization and conjugation strategies: application in preparation of stealth immunoliposome to target chemotherapeutics to tumor J. Control. Release 150 2011 2 22
14. M.N. Needle, P.T. Molloy, J.R. Geyer, A. Herman-Liu, J.B. Belasco, J.W. Goldwein, L. Sutton, and P.C. Phillips Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors Med. Pediatr. Oncol. 29 1997 28 32
15. M. Gordaliza, P.A. Garcia, J.M. del Corral, M.A. Castro, and M.A. Gomez-Zurita Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives Toxicon 44 2004 441 459
16. M. Snehalatha, K. Venugopal, R.N. Saha, A.K. Babbar, and R.K. Sharma Etoposide loaded PLGA and PCL nanoparticles II: biodistribution and pharmacokinetics after radiolabeling with Tc-99 m Drug. Deliv. 15 2008 277 287
17. Y.C. Kuo, and T.W. Lin Electrophoretic mobility, zeta potential, and fixed charge density of bovine knee chondrocytes, methyl methacrylate-sulfopropyl methacrylate, polybutylcyanoacrylate, and solid lipid nanoparticles J. Phys. Chem. B 110 2006 2202 2208
18. Y.C. Kuo, and I.C. Chen Evaluation of surface charge density and surface potential by electrophoretic mobility for solid lipid nanoparticles and human brain-microvascular endothelial cells J. Phys. Chem. B 111 2007 11228 11236
19. Y.C. Kuo, and F.L. Su Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles Int. J. Pharm. 340 2007 143 152
20. Y.C. Kuo, and C.H. Lu Effect of human astrocytes on the characteristics of human brain-microvascular endothelial cells in the blood-brain barrier Colloids Surf. B 86 2011 225 231
21. Y.C. Kuo, and C.H. Lu Modulation of efflux proteins by electromagnetic field for delivering azidothymidine and saquinavir into the brain Colloids Surf. B 91 2012 291 295
22. M.J. Clark, N. Homer, B.D. O'Connor, Z. Chen, A. Eskin, H. Lee, B. Merriman, and S.F. Nelson U87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line PLoS Genet. 6 2010 e1000832
23. K. Hac-Wydro, and P. Wydro The influence of fatty acids on model cholesterol/phospholipid membranes Chem. Phys. Lipids 150 2007 66 81
24. Y.C. Kuo, and C.Y. Chung Solid lipid nanoparticles comprising internal Compritol 888 ATO, tripalmitin and cacao butter for encapsulating and releasing stavudine, delavirdine and saquinavir Colloids Surf. B 88 2011 682 690
25. Y.C. Kuo, and C.W. Lin Effect of electromagnetic field and surface modification on the electrical behavior of novel solid lipid nanoparticles covered with L-arginine Colloids Surf. B 71 2009 45 51
26. M. Lutter, M. Fang, X. Luo, M. Nishijima, X. Xie, and X. Wang Cardiolipin provides specificity for targeting of tBid to mitochondria Nat. Cell Biol. 2 2000 754 756
27. J. Yu, D. Javier, M.A. Yaseen, N. Nitin, R. Richards-Kortum, B. Anvari, and M.S. Wong Self-assembly synthesis, tumor cell targeting, and photothermal capabilities of antibody-coated indocyanine green nanocapsules J. Am. Chem. Soc. 132 2010 1929 1938
28. M. Yoon, H.J. Hwang, and J.H. Kim Immobilization of antibodies on the self-assembled monolayer by antigen-binding site protection and immobilization kinetic control J. Biomed. Sci. Eng. 4 2011 242 247
29. F. Rusmini, Z. Zhong, and J. Feijen Protein immobilization strategies for protein biochips Biomacromolecules 8 2007 1775 1789
30. A.J. Almeida, and E. Souto Solid lipid nanoparticles as a drug delivery system for peptides and proteins Adv. Drug Deliv. Rev. 59 2007 478 490
31. S. Li, B. Zhao, F. Wang, M. Wang, S. Xie, and S. Wang Yak interferon-alpha loaded solid lipid nanoparticles for controlled release Res. Vet. Sci. 88 2010 148 153
32. Y.C. Kuo, and H.H. Chen Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles Int. J. Pharm. 365 2009 206 213
33. C.F. Jones, and D.W. Grainger In vitro assessments of nanomaterial toxicity Adv. Drug Deliv. Rev. 61 2009 438 456
34. Y.C. Kuo, and C.C. Wang Cationic solid lipid nanoparticles with primary and quaternary amines for release of saquinavir and biocompatibility with endothelia Colloids Surf. B 101 2013 101 105
35. S.A. Prigent, K.K. Stanley, and K. Siddle Identification of epitopes on the human insulin receptor reacting with rabbit polyclonal antisera and mouse monoclonal antibodies J. Biol. Chem. 265 1990 9970 9977
36. A.R. Jones, and E.V. Shusta Blood-brain barrier transport of therapeutics via receptor-mediation Pharm. Res. 24 2007 1759 1771
37. R.H. Muller, S. Maassen, H. Weyhers, F. Specht, and J.S. Lucks Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles Int. J. Pharm. 138 1996 85 94
38. Y.C. Kuo, and J.F. Chung Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers Colloids Surf. B 83 2011 299 306
39. Y.C. Kuo, and P.R. Chou Neuroprotection against degeneration of SK-N-MC cells using neuron growth factor-encapsulated liposomes with surface cereport and transferring J. Pharm. Sci. 103 2014 2484 2497
40. E. Dejana Endothelial cell-cell junctions: happy together Nat. Rev. Mol. Cell Biol. 5 2004 261 270
41. Y.C. Kuo, and C.Y. Kuo Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers Int. J. Pharm. 351 2008 271 281
42. P.J. Gaillard, and A.G. de Boer Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug Eur. J. Pharm. Sci. 12 2000 95 102
43. Y.C. Kuo, and C.H. Lu Regulation of endocytosis into human brain-microvascular endothelial cells by inhibition of efflux proteins Colloids Surf. B 87 2011 139 145
44. M.K. Callahan, K.A. Williams, P. Kivisakk, D. Pearce, M.F. Stins, and R.M. Ransohoff CXCR3 marks CD4 + memory T lymphocytes that are competent to migrate across a human brain microvascular endothelial cell layer J. Neuroimmunol. 153 2004 150 157
45. N.F. Flecher, D.J. Brayden, B. Brankin, S. Worrall, and J.J. Callanan Growth and characterisation of a cell culture model of the feline blood-brain barrier Vet. Immunol. Immunopathol. 109 2006 233 244
46. Y.C. Kuo, and L.J. Wang Transferrin-grafted catanionic solid lipid nanoparticles for targeting delivery of saquinavir to the brain J. Taiwan Inst. Chem. Eng. 45 2014 755 763
47. S. Kishi, W. Yang, B. Boureau, S. Morand, S. Das, P. Chen, E.H. Cook, G.L. Rosner, E. Schuetz, C.H. Pui, and M.V. Relling Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia Blood 103 2004 67 72
48. I.A. Najar, S.C. Sharma, G.D. Singh, S. Koul, P.N. Gupta, S. Javed, and R.K. Johri Involvement of P-glycoprotein and CYP 3A4 in the enhancement of etoposide bioavailability by a piperine analogue Chem. Biol. Interact. 190 2011 84 90
49. G. Zhao, J. Huang, K. Xue, L. Si, and G. Li Enhanced intestinal absorption of etoposide by self-microemulsifying drug delivery systems: roles of P-glycoprotein and cytochrome P4503A inhibition Eur. J. Pharm. Sci. 50 2013 429 439
50. M.K. Spigelman, R.A. Zappulla, J.A. Strauchen, E.J. Feuer, J. Johnson, S.J. Goldsmith, L.I. Malis, and J.F. Holland Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae Cancer Res. 46 1986 1453 1457
51. W.M. Pardridge Drug targeting to the brain Pharm. Res. 24 2007 1733 1744
52. M.K. Spigelman, R.A. Zappulla, J.D. Goldberg, S.J. Goldsmith, D. Marotta, and L.I. Malis Effect of intracarotid etoposide on opening the blood-brain barrier Cancer Drug Deliv. 1 1984 207 211
53. W.M. Pardridge, Y.S. Kang, J.L. Buciak, and J. Yang Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate Pharm. Res. 12 1995 807 816
54. L.R. Walus, W.M. Pardridge, R.M. Starzyk, and P.M. Friden Enhanced uptake of rsCD4 across the rodent and primate blood-brain barrier following conjugation to anti-transferrin receptor antibodies J. Pharmacol. Exp. Ther. 277 1996 1067 1075
55. Y. Malam, M. Loizidou, and A.M. Seifalian Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer Trends Pharmacol. Sci. 30 2009 592 599
56. L. Juillerat-Jeanneret The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles? Drug Discov. Today 13 2008 1099 1106
57. Y.C. Kuo, and H.H. Chen Effect of electromagnetic field on endocytosis of cationic solid lipid nanoparticles by human brain-microvascular endothelial cells J. Drug Target. 18 2010 447 456
58. C. Ortiz, L. Caja, P. Sancho, E. Bertran, and I. Fabregat Inhibition of the EGF receptor blocks autocrine growth and increases the cytotoxic effects of doxorubicin in rat hepatoma cells: role of reactive oxygen species production and glutathione depletion Biochem. Pharmacol. 75 2008 1935 1945